FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jerome Kim

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Anatomy

Physiology

Lymphocyte Activation

Co-author Network

Publications

TOP 3
Supachai Rerks-Ngarm; Merlin L Robb; Jim Tartaglia; Prasert Thongcharoen; Rapee Trichavaroj; Elizabeth Adams; Charla Andrews; Chureeratana Bowonwatanuwong; Supamit Chunsutthiwat; Nampueng Churikanont; Mark de Souza; Chirapa Eamsila; Jorge Flores; Donald Francis; Peter B Gilbert; Sanjay Gurunathan; Jaranit Kaewkungkal; Prayura Kunasol; Shuying S Li; Nelson L Michael; Chawetsan Namwat; Viseth Ngauy; Sorachai Nitayaphan; Robert J O'Connell; Robert M Paris; Nakorn Premsri; Jerome H Kim
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
Mattia Bonsignori; Xi Chen; Anthony DeVico; David T Evans; Guido Ferrari; Peter B Gilbert; Thaddeus C Gurley; Michael D Alpert; Ying Huang; Kwan-Ki Hwang; Jaranit Kaewkungwal; Jerome H Kim; Daniel M Kozink; George K Lewis; Hua-Xin Liao; Dawn J Marshall; Nelson L Michael; David C Montefiori; M Anthony Moody; Sorachai Nitayaphan; Punnee Pitisuttithum; Justin Pollara; Supachai Rerks-Ngarm; Georgia D Tomaras; Chun-Yen Tsao; John F Whitesides; Barton F Haynes
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family.
Merlin L Robb; Don Stablein; Jim Tartaglia; Prasert Thongcharoen; Prayura Kunasol; Nelson L Michael; Patricia Morgan; Sorachai Nitayaphan; Robert M Paris; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Elizabeth Adams; Michael Benenson; Joseph Chiu; Donald Francis; Peter Gilbert; Sanjay Gurunathan; Jaranit Kaewkungwal; Chirasak Khamboonruang; Jerome H Kim
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jerome Kim (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Supachai Rerks-Ngarm; Merlin L Robb; Jim Tartaglia; Prasert Thongcharoen; Rapee Trichavaroj; Elizabeth Adams; Charla Andrews; Chureeratana Bowonwatanuwong; Supamit Chunsutthiwat; Nampueng Churikanont; Mark de Souza; Chirapa Eamsila; Jorge Flores; Donald Francis; Peter B Gilbert; Sanjay Gurunathan; Jaranit Kaewkungkal; Prayura Kunasol; Shuying S Li; Nelson L Michael; Chawetsan Namwat; Viseth Ngauy; Sorachai Nitayaphan; Robert J O'Connell; Robert M Paris; Nakorn Premsri; Jerome H Kim
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
The Journal of infectious diseases 2013;207(8):1195-205.
2012: Mattia Bonsignori; Xi Chen; Anthony DeVico; David T Evans; Guido Ferrari; Peter B Gilbert; Thaddeus C Gurley; Michael D Alpert; Ying Huang; Kwan-Ki Hwang; Jaranit Kaewkungwal; Jerome H Kim; Daniel M Kozink; George K Lewis; Hua-Xin Liao; Dawn J Marshall; Nelson L Michael; David C Montefiori; M Anthony Moody; Sorachai Nitayaphan; Punnee Pitisuttithum; Justin Pollara; Supachai Rerks-Ngarm; Georgia D Tomaras; Chun-Yen Tsao; John F Whitesides; Barton F Haynes
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family.
Journal of virology 2012;86(21):11521-32.
2012: Merlin L Robb; Don Stablein; Jim Tartaglia; Prasert Thongcharoen; Prayura Kunasol; Nelson L Michael; Patricia Morgan; Sorachai Nitayaphan; Robert M Paris; Punnee Pitisuttithum; Supachai Rerks-Ngarm; Elizabeth Adams; Michael Benenson; Joseph Chiu; Donald Francis; Peter Gilbert; Sanjay Gurunathan; Jaranit Kaewkungwal; Chirasak Khamboonruang; Jerome H Kim
Risk behaviour and time as covariates for efficacy of the HIV vaccine regimen ALVAC-HIV (vCP1521) and AIDSVAX B/E: a post-hoc analysis of the Thai phase 3 efficacy trial RV 144.
The Lancet infectious diseases 2012;12(7):531-7.
2012: Mark S de Souza; Jaranit Kaewkungwal; Jerome H Kim; Mary A Marovich; Bonnie Mathieson; Nelson L Michael; Sorachai Nitayaphan; Bessara Nuntapinit; Robert M Paris; Punnee Pitisuttithum; Silvia Ratto-Kim; Supachai Rerks-Ngarm; Alexandra Schuetz; Doris Thelian; Anais Valencia-Micolta; Somsak Chantakulkij; Weerawan Chuenarom; Jeffrey R Currier
The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.
Journal of immunology (Baltimore, Md. : 1950) 2012;188(10):5166-76.
2012: Fatima Rangwala; Chureeratana Bowonwatanuwong; G Ralph Corey; Nneka Edwards-Jackson; Jerome H Kim; Siriluck Kramomthong; Opass Putcharoen; Jintanat Ananworanich
Histoplasmosis and penicilliosis among HIV-infected Thai patients: a retrospective review.
The Southeast Asian journal of tropical medicine and public health 2012;43(2):436-41.
2012: Robert Paris; Punnee Pitisuttithum; Victoria R Polonis; Silvia Ratto-Kim; Anna Sambor; Henry A Stephens; Prasert Thongcharoen; Sasitorn Bejrachandra; Arthur E Brown; Mark de Souza; Donald Francis; Sanjay Gurunathan; Chitraporn Karnasuta; Jerome H Kim; Sorachai Nitayaphan
HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.
Vaccine 2012;30(5):832-6.
2010: Gary R Matyas; Lindsay Wieczorek; Divya Bansal; Agnes-Laurence Chenine; eric sanders-buell; Sodsai Tovanabutra; Jerome H Kim; Victoria R Polonis; Carl R Alving
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines.
Biochemical and biophysical research communications 2010;402(4):808-12.
2010: Jerome H Kim; Supachai Rerks-Ngarm; Jean-Louis Excler; Nelson L Michael
HIV vaccines: lessons learned and the way forward.
Current opinion in HIV and AIDS 2010;5(5):428-34.
2009: Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jaranit Kaewkungwal; Joseph Chiu; Robert Paris; Nakorn Premsri; Chawetsan Namwat; Mark de Souza; Elizabeth Adams; Michael Benenson; Sanjay Gurunathan; Jim Tartaglia; John G McNeil; Donald P Francis; Donald Stablein; Deborah L Birx; Supamit Chunsuttiwat; Chirasak Khamboonruang; Prasert Thongcharoen; Merlin L Robb; Nelson L Michael; Prayura Kunasol; Jerome H Kim
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
The New England journal of medicine 2009;361(23):2209-20.
2009: Victor Valcour; Bruce Shiramizu; Pasiri Sithinamsuwan; Samart Nidhinandana; Silvia Ratto-Kim; J Ananworanich; U Siangphoe; Jerome H Kim; Mark de Souza; V Degruttola; R H Paul; Cecilia M Shikuma
HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study.
Neurology 2009;72(11):992-8.
2008: Silvia Ratto-Kim; Thippawan Chuenchitra; Lynn Pulliam; Robert Paris; Suchitra Sukwit; Siriphan Gongwon; Pasiri Sithinamsuwan; Samart Nidhinandana; Sataporn Thitivichianlert; Bruce Shiramizu; Mark de Souza; Suwicha T Chitpatima; Bing Sun; Hans Rempel; Sorachai Nitayaphan; Kenneth Williams; Jerome H Kim; Cecilia M Shikuma; Victor Valcour
Expression of monocyte markers in HIV-1 infected individuals with or without HIV associated dementia and normal controls in Bangkok Thailand.
Journal of neuroimmunology 2008;195(1-2):100-7.
2007: Prasert Thongcharoen; Vinai Suriyanon; Robert M Paris; Chirasak Khamboonruang; Mark de Souza; Silvia Ratto-Kim; Chitraporn Karnasuta; Victoria R Polonis; Lynn Baglyos; Raphaelle El Habib; Sanjay Gurunathan; Susan Barnett; Arthur E Brown; Deborah L Birx; John G McNeil; Jerome H Kim
A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.
Journal of acquired immune deficiency syndromes (1999) 2007;46(1):48-55.
2005: Cecilia M Shikuma; Victor Valcour; Silvia Ratto-Kim; Andrew Williams; Scott Souza; Mariana Gerschenson; Larry Day; Jerome H Kim; Bruce Shiramizu
HIV-associated wasting in the era of highly active antiretroviral therapy: a syndrome of residual HIV infection in monocytes and macrophages?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(12):1846-8.
2004: Silvia Ratto-Kim; Robin P Garner; Jerome H Kim; Linda L Jagodzinski; Nelson L Michael; Robert M Paris; Robert R Redfield; Deborah L Birx
Prospective analyses of HIV-1-specific proliferative responses, recall antigen proliferative responses, and clinical outcomes in an HIV-1-seropositive cohort.
The Journal of infectious diseases 2004;189(11):1988-95.
2003: Silvia Ratto-Kim; Lawrence D Loomis-Price; Naomi E Aronson; Janelle Grimes; Cristin Hill; Chevelle Williams; Raphaelle El Habib; Deborah L Birx; Jerome H Kim
Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.
Journal of acquired immune deficiency syndromes (1999) 2003;32(1):9-17.
2001: Jerome H Kim; John R Mascola; Silvia Ratto-Kim; Thomas C VanCott; Lawrence D Loomis-Price; Josephine H Cox; Nelson L Michael; Linda L Jagodzinski; C Hawkes; DL Mayers; Bruce L Gilliam; D C Birx; Merlin L Robb
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.
AIDS research and human retroviruses 2001;17(11):1021-34.
1999: Silvia Ratto-Kim; KV Sitz; Robin P Garner; Jerome H Kim; Charles Davis; Naomi E Aronson; N Ruiz; K Tencer; Robert R Redfield; Deborah L Birx
Repeated immunization with recombinant gp160 human immunodeficiency virus (HIV) envelope protein in early HIV-1 infection: evaluation of the T cell proliferative response.
The Journal of infectious diseases 1999;179(2):337-44.
1997: Silvia Ratto-Kim; KV Sitz; A M Scherer; Jerome H Kim; D W Anderson; M E Nau; Dean L Mann; Pradip N Akolkar; Beena Gulwani-Akolkar; Jack Silver; Deborah L Birx
Comparison of HIV-1 envelope-specific CD4+ T cell lines simultaneously established from peripheral blood mononuclear cells and lymph node biopsy in HIV-1-infected individuals.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(10):5162-7.
1997: Jerome H Kim; J E Loveland; KV Sitz; Silvia Ratto-Kim; R J Mclinden; K Tencer; K Davis; Donald S. Burke; R N Boswell; Robert R Redfield; Deborah L Birx
Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1.
Clinical and experimental immunology 1997;108(2):243-50.
1996: Jerome H Kim; R J McLinden; Joseph Mosca; Maryanne Vahey; Warner Greene; Robert R Redfield
Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(4):343-51.
1996: Jerome H Kim; R J McLinden; Joseph Mosca; Donald S. Burke; R N Boswell; Deborah L Birx; Robert R Redfield
Transcriptional effects of superinfection in HIV chronically infected T cells: studies in dually infected clones.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;12(4):329-42.
1994: Jerome H Kim; S Ratto; KV Sitz; Joseph Mosca; R J McLinden; K L Tencer; Maryanne Vahey; DC St Louis; Deborah L Birx; Robert R Redfield
Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cells.
Human gene therapy 1994;5(12):1457-66.
1993: Jerome H Kim; Joseph Mosca; Maryanne Vahey; R J McLinden; Donald S. Burke; Robert R Redfield
Consequences of human immunodeficiency virus type 1 superinfection of chronically infected cells.
AIDS research and human retroviruses 1993;9(9):875-82.